ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation
- PMID: 23606453
- DOI: 10.1002/humu.22342
ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation
Abstract
Limb girdle muscular dystrophy type 2L or anoctaminopathy is a condition mainly characterized by adult onset proximal lower limb muscular weakness and raised CK values, due to recessive ANO5 gene mutations. An exon 5 founder mutation (c.191dupA) has been identified in most of the British and German LGMD2L patients so far reported. We aimed to further investigate the prevalence and spectrum of ANO5 gene mutations and related clinical phenotypes, by screening 205 undiagnosed patients referred to our molecular service with a clinical suspicion of anoctaminopathy. A total of 42 unrelated patients had two ANO5 mutations (21%), whereas 14 carried a single change. We identified 34 pathogenic changes, 15 of which are novel. The c.191dupA mutation represents 61% of mutated alleles and appears to be less prevalent in non-Northern European populations. Retrospective clinical analysis corroborates the prevalently proximal lower limb phenotype, the male predominance and absence of major cardiac or respiratory involvement. Identification of cases with isolated hyperCKaemia and very late symptomatic male and female subjects confirms the extension of the phenotypic spectrum of the disease. Anoctaminopathy appears to be one of the most common adult muscular dystrophies in Northern Europe, with a prevalence of about 20%-25% in unselected undiagnosed cases.
Keywords: ANO5; LGMD2L; gender; muscular dystrophy.
© 2013 WILEY PERIODICALS, INC.
Similar articles
-
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.Brain. 2011 Jan;134(Pt 1):171-182. doi: 10.1093/brain/awq294. Brain. 2011. PMID: 21186264 Free PMC article.
-
Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.Neuromuscul Disord. 2012 Nov;22(11):934-43. doi: 10.1016/j.nmd.2012.05.001. Epub 2012 Jun 27. Neuromuscul Disord. 2012. PMID: 22742934 Free PMC article.
-
Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.Neurology. 2012 Mar 20;78(12):897-903. doi: 10.1212/WNL.0b013e31824c4682. Epub 2012 Mar 7. Neurology. 2012. PMID: 22402862
-
Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.Genes (Basel). 2022 Sep 27;13(10):1736. doi: 10.3390/genes13101736. Genes (Basel). 2022. PMID: 36292621 Free PMC article. Review.
-
The limb-girdle muscular dystrophies.Neurol Clin. 2014 Aug;32(3):729-49, ix. doi: 10.1016/j.ncl.2014.04.005. Neurol Clin. 2014. PMID: 25037088 Review.
Cited by
-
Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study.J Neurol Neurosurg Psychiatry. 2022 Jul 27:jnnp-2022-328921. doi: 10.1136/jnnp-2022-328921. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35896379 Free PMC article.
-
ANO5-related muscle diseases: From clinics and genetics to pathology and research strategies.Genes Dis. 2022 Feb 14;9(6):1506-1520. doi: 10.1016/j.gendis.2022.01.001. eCollection 2022 Nov. Genes Dis. 2022. PMID: 36157496 Free PMC article. Review.
-
Robust genotyping tool for autosomal recessive type of limb-girdle muscular dystrophies.BMC Musculoskelet Disord. 2016 May 4;17:200. doi: 10.1186/s12891-016-1058-z. BMC Musculoskelet Disord. 2016. PMID: 27142102 Free PMC article.
-
Endoplasmic reticulum maintains ion homeostasis required for plasma membrane repair.J Cell Biol. 2021 May 3;220(5):e202006035. doi: 10.1083/jcb.202006035. J Cell Biol. 2021. PMID: 33688936 Free PMC article.
-
ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.Sci Rep. 2019 Aug 8;9(1):11533. doi: 10.1038/s41598-019-47849-3. Sci Rep. 2019. PMID: 31395899 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials